Nesbitt et al., 1994 - Google Patents
Effect of substrate on mass release from ethylcellulose latex coated pelletsNesbitt et al., 1994
- Document ID
- 7113058970464566077
- Author
- Nesbitt R
- Mahjour M
- Mills N
- Fawzi M
- Publication year
- Publication venue
- Journal of controlled release
External Links
Snippet
The release of water soluble substrates from Aquacoat coated pellets was through water- filled channels. Each pellet works like a mini osmotic pump with many orifices (pores). The energy to drive the system was supplied by the osmotic pressure differences generated …
- 239000008188 pellet 0 title abstract description 86
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zentner et al. | The controlled porosity osmotic pump | |
US5612059A (en) | Use of asymmetric membranes in delivery devices | |
Ozturk et al. | Mechanism of release from pellets coated with an ethylcellulose-based film | |
EP0357369B1 (en) | The use of asymetric membranes in delivery devices | |
EP1010423B1 (en) | Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production | |
JP2750150B2 (en) | Osmotic continuous dispersible oral projection system containing pharmaceutically acceptable active agents with improved core membrane adhesion properties | |
JP4703470B2 (en) | Controlled release formulation coated with ethyl cellulose aqueous dispersion | |
EP1027888B1 (en) | Osmotic system for delivery of solid amorphous dispersions of drugs | |
JP2847326B2 (en) | Supported liquid membrane delivery device | |
JP2003528910A (en) | Preparation of controlled release formulations | |
SK143296A3 (en) | Controlled-release dosage forms of azithromycin | |
CA2000932C (en) | Oral pharmaceutical controlled release multiple unit dosage form | |
Zhang et al. | Bead coating. I. Change in release kinetics (and mechanism) due to coating levels | |
FI65911C (en) | OEVERDRAG SOM GARANTERAR EN KONTROLLERAD FRIGOERING AV AKTIVA BESTAONDSDELAR UR BIOLOGISKT AKTIVA PREPARAT SPECIELLT UR FAMACEUTISKA PREPARAT OCH FOERFARANDE FOER FRAMSTAELLNING A V IOLOGISKT AKTIVA VEPARAT UEP | |
Nesbitt et al. | Effect of substrate on mass release from ethylcellulose latex coated pellets | |
Yuen et al. | Development and in-vitro evaluation of a multiparticulate sustained release theophylline formulation | |
Kranz et al. | Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers | |
US20040058000A1 (en) | Controlled release capsule for delivery of liquid formulation | |
WO2002049621A1 (en) | Enteric-coated drug formulations and their manufacture | |
WO2004112746A1 (en) | Controlled release-drug delivery system for oral administration | |
WO2004058257A1 (en) | Controlled release formulation comprising benzimidazole derivatives or pharmaceutically acceptable salts thereof with increased stability and method for preparing the same | |
Mehta | Factors in the development of oral controlled release dosage forms | |
Kim et al. | Influence of water soluble additives and HPMCP on drug release from sureleaseê-coated pellets containing tamsulosin hydrochloride | |
Nimmannit et al. | Microencapsulation of drugs by the coacervation technique using ethylcellulose and acrylate-methacrylate copolymer as wall materials | |
Jambhekar et al. | Influence of formulation and other factors on the release of chlorpheniramine mateate from polymer coated beads |